Testing a lung tumor's genome for alterations is helping patients get treatments matched to their disease, US News & World Report says.

About 60 percent of lung adenocarcinomas harbor specific gene mutations that may be key drivers of disease, it says, adding that by targeting these changes, clinicians may be better able to treat the disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.